Report - Labor im Dialog - haemostasikum.de€¦ · Antikörper gegen Tissue factor pathway inhibitor (Concizumab) 2. RNAi zur Blockade der Expression von Antithrombin (Fitusiran) 3. Gentherapie

Please pass captcha verification before submit form